Development, Characterization, and Evaluation of α-Mangostin-Loaded Polymeric Nanoparticle Gel for Topical Therapy in Skin Cancer
Authors:
- ShadabShadab
- Nabil A. AlhakamyNANabil A. Alhakamy
- Thikryat NeamatallahThikryat Neamatallah
- Samah AlshehriSamah Alshehri
- Ali MujtabaAli Mujtaba
- Yassine RiadiYassine Riadi
- Ammu K. RadhakrishnanAmmu K. Radhakrishnan
- Habibullah KhalilullahHabibullah Khalilullah
- Manish GuptaManish Gupta
- Habban AkhterHabban Akhter
Open Access
Abstract
The aim of this study was to prepare and evaluate α-mangostin-loaded polymeric nanoparticle gel (α-MNG-PLGA) formulation to enhance α-mangostin delivery in an epidermal carcinoma. The poly (D, L-lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) were developed using the emulsion–diffusion–evaporation technique with a 3-level 3-factor Box–Behnken design. The NPs were characterized and evaluated for particle size distribution, zeta potential (mV), drug release, and skin permeation. The formulated PLGA NPs were converted into a preformed carbopol gel base and were further evaluated for texture analysis, the cytotoxic effect of PLGA NPs against B16-F10 melanoma cells, and in vitro radical scavenging activity. The nanoscale particles were spherical, consistent, and average in size (168.06 ± 17.02 nm), with an entrapment efficiency (EE) of 84.26 ± 8.23% and a zeta potential of −25.3 ± 7.1 mV. Their drug release percentages in phosphate-buffered solution (PBS) at pH 7.4 and pH 6.5 were 87.07 ± 6.95% and 89.50 ± 9.50%, respectively. The release of α-MNG from NPs in vitro demonstrated that the biphasic release system, namely, immediate release in the initial phase, was accompanied by sustained drug release. The texture study of the developed α-MNG-PLGA NPs gel revealed its characteristics, including viscosity, hardness, consistency, and cohesiveness. The drug flux from α-MNG-PLGA NPs gel and α-MNG gel was 79.32 ± 7.91 and 16.88 ± 7.18 µg/cm2/h in 24 h, respectively. The confocal study showed that α-MNG-PLGA NPs penetrated up to 230.02 µm deep into the skin layer compared to 15.21 µm by dye solution. MTT assay and radical scavenging potential indicated that α-MNG-PLGA NPs gel had a significant cytotoxic effect and antioxidant effect compared to α-MNG gel (p < 0.05). Thus, using the developed α-MNG-PLGA in treating skin cancer could be a promising approach.Keywords
Funding Information
- King Abdulaziz University (RG-12–166–42)
This publication has 70 references indexed in Scilit:
- α-Mangostin Induces Apoptosis and Suppresses Differentiation of 3T3-L1 Cells via Inhibiting Fatty Acid SynthasePLOS ONE, 2012
- Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cellsBiomedicine & Preventive Nutrition, 2011
- The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulationBiomaterials, 2010
- Review: Ultraviolet radiation and skin cancerInternational Journal of Dermatology, 2010
- PLGA Erosion: Solubility- or Diffusion-Controlled?Pharmaceutical Research, 2010
- Chitosan nanoparticle as protein delivery carrier—Systematic examination of fabrication conditions for efficient loading and releaseColloids and Surfaces B: Biointerfaces, 2007
- Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug contentInternational Journal of Pharmaceutics, 2007
- Effect of drug type on the degradation rate of PLGA matricesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- The Epidemiologic Transition: A Theory of the Epidemiology of Population ChangeThe Milbank Quarterly, 2005
- Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removalBritish Journal of Dermatology, 2004